本页面由Tiger Trade Technology Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

39.53
-0.0800-0.20%
盘后39.530.00000.00%16:54 EDT
成交量:251.08万
成交额:9,928.81万
市值:61.10亿
市盈率:-27.08
高:39.63
开:39.60
低:39.49
收:39.61
52周最高:40.26
52周最低:10.95
股本:1.55亿
流通股本:8,933.05万
量比:0.82
换手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):-1.4600
每股收益(LYR):-1.4600
净资产收益率:-42.55%
总资产收益率:-20.53%
市净率:11.60
市盈率(LYR):-27.08

数据加载中...

2024/12/30

重要事件披露

Form 8-K - Current report
2024/12/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities